Prognostic relevance of cytogenetic subgroups in 357 patients with myelodysplastic syndromes.

被引：0
|
作者：
Haase, D [1 ]
Schanz, J [1 ]
Wulich, J [1 ]
Schoch, C [1 ]
Freund, M [1 ]
Haferlach, T [1 ]
Wormann, B [1 ]
Staib, P [1 ]
Lentini, G [1 ]
Bartels, H [1 ]
Geissler, RG [1 ]
Germing, U [1 ]
Dorges, U [1 ]
Fonatsch, C [1 ]
Hiddemann, W [1 ]
机构：
[1] UNIV GOTTINGEN,DEPT HEMATOL ONCOL,D-37075 GOTTINGEN,GERMANY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2232 / 2232
页数：1
相关论文
共 50 条
  • [1] Cytogenetic of myelodysplastic syndromes.
    Lai, JL
    Fenaux, P
    PATHOLOGIE BIOLOGIE, 1997, 45 (07): : 550 - 555
  • [2] Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.
    Pollio, B.
    Ciriello, M. M.
    Fruttero, A.
    Geuna, M.
    Iavarone, A.
    Omede, P.
    Pautasso, M.
    Pollono, A. M.
    Santagostino, A.
    Garbaccio Ioria, G.
    Stacchini, A.
    Gioia, D.
    Ferrero, D.
    Marmont, F.
    Gallamini, A.
    Saglio, G.
    Levis, Alessandro
    Girotto, M.
    BLOOD, 2006, 108 (11) : 740A - 740A
  • [3] Prognostic relevance of cytogenetic systems in myelodysplastic syndromes
    Belli, Carolina B.
    Bestach, Yesica
    Correa, Walter A.
    Sakamoto, Francisco
    Flores, Maria G.
    Basquiera, Ana L.
    Rivas, Maria M.
    Campestri, Reinaldo
    Bengio, Raquel
    Larripa, Irene
    LEUKEMIA & LYMPHOMA, 2012, 53 (08) : 1640 - 1642
  • [4] Relevance of prognostic factors in different subgroups of myelodysplastic syndromes
    Kuendgen, A.
    Strupp, C.
    Nachtkamp, K.
    Hildebrandt, B.
    Gattermann, N.
    Haas, R.
    Germing, U.
    LEUKEMIA RESEARCH, 2009, 33 : S32 - S33
  • [5] Prognostic classification in myelodysplastic syndromes.
    Sanz, GF
    Morel, P
    PATHOLOGIE BIOLOGIE, 1997, 45 (08): : 617 - 626
  • [6] Prognostic relevance of cytogenetic evolution and the influence of the clonal composition in patients with myelodysplastic syndromes
    Cevik, N.
    Haase, D.
    Schanz, J.
    ONKOLOGIE, 2013, 36 : 126 - 126
  • [7] Impact of complete cytogenetic response on survival in patients with myelodysplastic syndromes.
    Urrutia, Samuel
    Sasaki, Koji
    Kantarjian, Hagop M.
    Jabbour, Elias
    Chien, Kelly Sharon
    Hammond, Danielle
    Bueso-Ramos, Carlos E.
    Khoury, Joseph
    Patel, Keyur P.
    Montalban-Bravo, Guillermo
    Wei, Yue
    Colla, Simona
    Short, Nicholas James
    Daver, Naval Guastad
    Borthakur, Gautam
    Kadia, Tapan M.
    Pierce, Sherry
    Wierda, William G.
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Novel cytogenetic markers with prognostic relevance in myelodysplastic syndromes (MDS): A study on 491 patients
    Bernasconi, P.
    Mersy, C.
    Boni, M.
    Cavigliano, P. M.
    Calatroni, S.
    Giardini, I
    Rocca, B.
    Zappatore, R.
    Caresana, M.
    Dambruoso, I
    Astori, C.
    Lazzarino, M.
    Bernasconi, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 37 - 37
  • [9] The prognostic value of LDH in myelodysplastic syndromes.
    Wimazal, F
    Sperr, WR
    Kundi, M
    Fonatsch, C
    Thalhammer-Scherrer, R
    Wessel, S
    Meidlinger, P
    Schwarzinger, I
    Geissler, K
    Lechner, K
    Valent, P
    BLOOD, 1999, 94 (10) : 288B - 288B
  • [10] Hypoalbuminemia Is An Independent Prognostic Factor In Myelodysplastic Syndromes.
    Corrales-Yepez, Maria
    Kharfan-Dabaja, Mohamed A.
    Lancet, Jeffrey
    List, Alan F.
    Padron, Eric
    Rollison, Dana
    Epling-Burnette, P. K.
    Zhang, Ling
    Field, Teressa
    Pinilla-Ibarz, Javier
    Komrokji, Rami S.
    BLOOD, 2010, 116 (21) : 1631 - 1631
12345